Is Kimberly-Clark (KMB) a risky stock?
As of July 21, 2026, Clavix grades Kimberly-Clark (KMB) B- for risk, a composite score of 65 out of 100 on an A+ to F scale, which puts KMB in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind KMB's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how KMB scores on each, as of July 21, 2026.
What's moving KMB's risk right now
Company-specific signals Clavix flags behind KMB's current grade, drawn from recent news and filings as of July 21, 2026.
KBC Group raised its holdings, SteelPeak Wealth opened a new position, and Wealthfront Advisers boosted its stake by 37.3% during the first quarter. The buying points to steady institutional interest in the consumer staples maker.
MarketBeat reports an average 'Hold' recommendation from 16 covering analysts, with one buy rating and the rest clustered in the middle. KMB also appeared on MarketBeat's July 13 dividend-stock screen, reflecting its regular payout.
If new products keep winning volume and share gains, top-line revenue could grow and reinforce KMB's position in consumer staples. The article frames innovation as the main lever for future sales growth.
What a B- grade means
On the Clavix A+ to F scale, KMB's composite of 65 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell KMB or any security. Grades are risk indicators, not predictions of return. Data may be delayed.